Video

Quotient Sciences Capabilities Update November 2026: Bioavailability And Solubility

Poor solubility can turn a promising drug candidate into a costly development challenge. When exposure falls short in the clinic, traditional formulation strategies may send teams back through months of additional development. Translational pharmaceutics changes that dynamic by bringing formulation development, manufacturing, and clinical testing into a rapid, integrated cycle.

Instead of relying heavily on animal data to select formulations, developers can evaluate multiple approaches directly in humans and use emerging PK results to determine what happens next.

From solubility-enhancing technologies and formulation optimization to food-effect and dose-escalation studies, this approach creates opportunities to refine drug products while clinical development is already underway. Real-world examples show how human data can guide critical formulation decisions, improve exposure, and even revive compounds previously constrained by poor bioavailability.

Access The Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma